Tamthom Ngo Truong

Array ( [id] => 7691411 [patent_doc_number] => 20070232622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Small molecule toll-like receptor (TLR) antagonists' [patent_app_type] => utility [patent_app_number] => 11/543314 [patent_app_country] => US [patent_app_date] => 2006-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 36757 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232622.pdf [firstpage_image] =>[orig_patent_app_number] => 11543314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205836 [patent_doc_number] => 20070027318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Quinoline derivatives and quinazoline derivatives' [patent_app_type] => utility [patent_app_number] => 11/526739 [patent_app_country] => US [patent_app_date] => 2006-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66027 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027318.pdf [firstpage_image] =>[orig_patent_app_number] => 11526739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107946 [patent_doc_number] => 20070066824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'PREPARATION OF ALFUZOSIN' [patent_app_type] => utility [patent_app_number] => 11/534226 [patent_app_country] => US [patent_app_date] => 2006-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5497 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066824.pdf [firstpage_image] =>[orig_patent_app_number] => 11534226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7693911 [patent_doc_number] => 20070015775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'HETEROCYCLIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/532926 [patent_app_country] => US [patent_app_date] => 2006-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36151 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015775.pdf [firstpage_image] =>[orig_patent_app_number] => 11532926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149696 [patent_doc_number] => 20070049756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'ALFUZOSIN HYDROCHLORIDE POLYMORPHS' [patent_app_type] => utility [patent_app_number] => 11/467951 [patent_app_country] => US [patent_app_date] => 2006-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 4719 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049756.pdf [firstpage_image] =>[orig_patent_app_number] => 11467951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5662160 [patent_doc_number] => 20060252756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Azolo triazines and pyrimidines' [patent_app_type] => utility [patent_app_number] => 11/477680 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57947 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252756.pdf [firstpage_image] =>[orig_patent_app_number] => 11477680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32860 [patent_doc_number] => 07790733 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => '8-alkoxy or cycloalkoxy-4-methyl-3,4-dihydro-quinazolin-2-ylamines' [patent_app_type] => utility [patent_app_number] => 11/472084 [patent_app_country] => US [patent_app_date] => 2006-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6167 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790733.pdf [firstpage_image] =>[orig_patent_app_number] => 11472084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32858 [patent_doc_number] => 07790732 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => '5-Chloro-4-alkyl-3,4-dihydro-quinazolin-2-ylamine derivatives' [patent_app_type] => utility [patent_app_number] => 11/472081 [patent_app_country] => US [patent_app_date] => 2006-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6726 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790732.pdf [firstpage_image] =>[orig_patent_app_number] => 11472081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5242941 [patent_doc_number] => 20070021436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'INTERMEDIATES USEFUL IN THE SYNTHESIS OF ALKYLQUINOLINE AND ALKYLQUINAZOLINE KINASE MODULATORS, AND RELATED METHODS OF SYNTHESIS' [patent_app_type] => utility [patent_app_number] => 11/422352 [patent_app_country] => US [patent_app_date] => 2006-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25386 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021436.pdf [firstpage_image] =>[orig_patent_app_number] => 11422352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5172452 [patent_doc_number] => 20070072885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'BICYCLIC DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH' [patent_app_type] => utility [patent_app_number] => 11/422235 [patent_app_country] => US [patent_app_date] => 2006-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18003 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072885.pdf [firstpage_image] =>[orig_patent_app_number] => 11422235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4983485 [patent_doc_number] => 20070088044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'Quinazoline derivatives as antitumor agents' [patent_app_type] => utility [patent_app_number] => 11/443395 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 89806 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20070088044.pdf [firstpage_image] =>[orig_patent_app_number] => 11443395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705913 [patent_doc_number] => 20060194961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Quinazoline(di)ones for invertebrate pest control' [patent_app_type] => utility [patent_app_number] => 11/417454 [patent_app_country] => US [patent_app_date] => 2006-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36192 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194961.pdf [firstpage_image] =>[orig_patent_app_number] => 11417454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5609143 [patent_doc_number] => 20060270659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Pyrazolopyrimidines as CRF receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/413610 [patent_app_country] => US [patent_app_date] => 2006-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12697 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270659.pdf [firstpage_image] =>[orig_patent_app_number] => 11413610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5662183 [patent_doc_number] => 20060252779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => '(3,4-Dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amine' [patent_app_type] => utility [patent_app_number] => 11/412432 [patent_app_country] => US [patent_app_date] => 2006-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11583 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252779.pdf [firstpage_image] =>[orig_patent_app_number] => 11412432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 578080 [patent_doc_number] => 07456188 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-11-25 [patent_title] => 'C-5 substituted quinazolinone derivatives as selective estrogen receptor beta modulators' [patent_app_type] => utility [patent_app_number] => 11/411456 [patent_app_country] => US [patent_app_date] => 2006-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10899 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/456/07456188.pdf [firstpage_image] =>[orig_patent_app_number] => 11411456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859924 [patent_doc_number] => 20060229323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => '(3,4-Dihydro-quinazolin-2-yl)-indan-1-yl-amines' [patent_app_type] => utility [patent_app_number] => 11/399790 [patent_app_country] => US [patent_app_date] => 2006-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5832 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20060229323.pdf [firstpage_image] =>[orig_patent_app_number] => 11399790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 876480 [patent_doc_number] => 07358256 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'ATP competitive kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/389797 [patent_app_country] => US [patent_app_date] => 2006-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11932 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358256.pdf [firstpage_image] =>[orig_patent_app_number] => 11389797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760771 [patent_doc_number] => 20060211716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => '(3,4-Dihydro-quinazolin-2-yl)-aryl-amines' [patent_app_type] => utility [patent_app_number] => 11/370669 [patent_app_country] => US [patent_app_date] => 2006-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4572 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211716.pdf [firstpage_image] =>[orig_patent_app_number] => 11370669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625915 [patent_doc_number] => 20060264420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Compounds, compositions, and methods' [patent_app_type] => utility [patent_app_number] => 11/370263 [patent_app_country] => US [patent_app_date] => 2006-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17062 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264420.pdf [firstpage_image] =>[orig_patent_app_number] => 11370263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4442446 [patent_doc_number] => 07928107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Quinazolines useful as modulators of ion channels' [patent_app_type] => utility [patent_app_number] => 11/367954 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 104985 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/928/07928107.pdf [firstpage_image] =>[orig_patent_app_number] => 11367954 [rel_patent_id] =>[rel_patent_doc_number] =>)